Journal
SCIENCE
Volume 328, Issue 5983, Pages 1290-1294Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1188635
Keywords
-
Categories
Funding
- Medical Research Council UK
- Biomedical Research Council of Singapore
- Swiss National Foundation
- German Research Foundation
- Medical Research Council [G0700794] Funding Source: researchfish
Ask authors/readers for more resources
During sepsis, activation of phagocytes leads to the overproduction of proinflammatory cytokines, causing systemic inflammation. Despite substantial information regarding the underlying molecular mechanisms that lead to sepsis, several elements in the pathway remain to be elucidated. We found that the enzyme sphingosine kinase 1 (SphK1) is up-regulated in stimulated human phagocytes and in peritoneal phagocytes of patients with severe sepsis. Blockade of SphK1 inhibited phagocyte production of endotoxin-induced proinflammatory cytokines. We observed protection against sepsis in mice treated with a specific SphK1 inhibitor that was enhanced by treatment with a broad-spectrum antibiotic. These results demonstrated a critical role for SphK1 in endotoxin signaling and sepsis-induced inflammatory responses and suggest that inhibition of SphK1 is a potential therapy for septic shock.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available